Technical Analysis for CDAK - Codiak BioSciences, Inc.

Grade Last Price % Change Price Change
F 14.54 -6.13% -0.95
CDAK closed down 6.13 percent on Monday, April 12, 2021, on 89 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical CDAK trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish -6.13%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.13%
Wide Bands Range Expansion -6.13%
Up 3 Days in a Row Strength -6.13%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.07%
MACD Bullish Signal Line Cross Bullish 0.07%
Narrow Range Bar Range Contraction 0.07%
Wide Bands Range Expansion 0.07%
Oversold Stochastic Weakness 0.07%
Older End-of-Day Signals for CDAK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Non-ADX 1,2,3,4 Bearish Retracement Entry about 4 hours ago
Fell Below Previous Day's Low about 4 hours ago
Fell Below 10 DMA about 5 hours ago
Down 10% about 5 hours ago
60 Minute Opening Range Breakdown about 6 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Biology Diseases Disease Urology Neurology Infectious Disease Exosome Neuromuscular Disease Vesicles

Is CDAK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.85
52 Week Low 7.9
Average Volume 144,630
200-Day Moving Average 0.00
50-Day Moving Average 18.35
20-Day Moving Average 15.45
10-Day Moving Average 14.26
Average True Range 1.66
ADX 17.52
+DI 19.25
-DI 20.30
Chandelier Exit (Long, 3 ATRs ) 13.85
Chandelier Exit (Short, 3 ATRs ) 17.69
Upper Bollinger Band 18.47
Lower Bollinger Band 12.43
Percent B (%b) 0.35
BandWidth 39.12
MACD Line -1.08
MACD Signal Line -1.28
MACD Histogram 0.199
Fundamentals Value
Market Cap 270.36 Million
Num Shares 18.6 Million
EPS
Price-to-Sales 214.13
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.72
Resistance 3 (R3) 16.75 16.05 16.35
Resistance 2 (R2) 16.05 15.50 16.04 16.23
Resistance 1 (R1) 15.30 15.16 14.95 15.27 16.11
Pivot Point 14.60 14.60 14.43 14.59 14.60
Support 1 (S1) 13.85 14.05 13.50 13.82 12.97
Support 2 (S2) 13.15 13.71 13.14 12.85
Support 3 (S3) 12.40 13.15 12.73
Support 4 (S4) 12.37